vs
Side-by-side financial comparison of ORTHOPEDIATRICS CORP (KIDS) and Lifeway Foods, Inc. (LWAY). Click either name above to swap in a different company.
ORTHOPEDIATRICS CORP is the larger business by last-quarter revenue ($61.6M vs $55.4M, roughly 1.1× Lifeway Foods, Inc.). Lifeway Foods, Inc. runs the higher net margin — 4.6% vs -16.4%, a 21.0% gap on every dollar of revenue. On growth, Lifeway Foods, Inc. posted the faster year-over-year revenue change (18.0% vs 17.0%). ORTHOPEDIATRICS CORP produced more free cash flow last quarter ($9.7M vs $-17.4M). Over the past eight quarters, ORTHOPEDIATRICS CORP's revenue compounded faster (17.4% CAGR vs 11.4%).
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
Lifeway Foods is an Illinois-based health food company founded in 1986. They are a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome.
KIDS vs LWAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $61.6M | $55.4M |
| Net Profit | $-10.1M | $2.5M |
| Gross Margin | 73.2% | 27.8% |
| Operating Margin | -13.3% | 6.8% |
| Net Margin | -16.4% | 4.6% |
| Revenue YoY | 17.0% | 18.0% |
| Net Profit YoY | 37.1% | 1688.1% |
| EPS (diluted) | $-0.43 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.6M | $55.4M | ||
| Q3 25 | $61.3M | $57.1M | ||
| Q2 25 | $61.1M | $53.9M | ||
| Q1 25 | $52.4M | $46.1M | ||
| Q4 24 | $52.7M | $46.9M | ||
| Q3 24 | $54.6M | $46.1M | ||
| Q2 24 | $52.8M | $49.2M | ||
| Q1 24 | $44.7M | $44.6M |
| Q4 25 | $-10.1M | $2.5M | ||
| Q3 25 | $-11.8M | $3.5M | ||
| Q2 25 | $-7.1M | $4.2M | ||
| Q1 25 | $-10.7M | $3.5M | ||
| Q4 24 | $-16.1M | $-160.0K | ||
| Q3 24 | $-7.9M | $3.0M | ||
| Q2 24 | $-6.0M | $3.8M | ||
| Q1 24 | $-7.8M | $2.4M |
| Q4 25 | 73.2% | 27.8% | ||
| Q3 25 | 73.9% | 28.7% | ||
| Q2 25 | 72.1% | 28.6% | ||
| Q1 25 | 73.0% | 23.9% | ||
| Q4 24 | 67.5% | 25.3% | ||
| Q3 24 | 73.4% | 25.7% | ||
| Q2 24 | 77.3% | 27.0% | ||
| Q1 24 | 72.0% | 25.8% |
| Q4 25 | -13.3% | 6.8% | ||
| Q3 25 | -15.4% | 8.8% | ||
| Q2 25 | -17.4% | 10.8% | ||
| Q1 25 | -21.0% | 3.4% | ||
| Q4 24 | -26.7% | 1.5% | ||
| Q3 24 | -10.2% | 9.1% | ||
| Q2 24 | -10.7% | 11.0% | ||
| Q1 24 | -21.8% | 8.0% |
| Q4 25 | -16.4% | 4.6% | ||
| Q3 25 | -19.2% | 6.2% | ||
| Q2 25 | -11.6% | 7.9% | ||
| Q1 25 | -20.3% | 7.7% | ||
| Q4 24 | -30.5% | -0.3% | ||
| Q3 24 | -14.5% | 6.5% | ||
| Q2 24 | -11.4% | 7.7% | ||
| Q1 24 | -17.5% | 5.4% |
| Q4 25 | $-0.43 | $0.15 | ||
| Q3 25 | $-0.50 | $0.23 | ||
| Q2 25 | $-0.30 | $0.28 | ||
| Q1 25 | $-0.46 | $0.23 | ||
| Q4 24 | $-0.70 | $0.00 | ||
| Q3 24 | $-0.34 | $0.19 | ||
| Q2 24 | $-0.26 | $0.25 | ||
| Q1 24 | $-0.34 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.9M | $5.6M |
| Total DebtLower is stronger | $106.0M | — |
| Stockholders' EquityBook value | $346.6M | $85.8M |
| Total Assets | $508.6M | $105.6M |
| Debt / EquityLower = less leverage | 0.31× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.9M | $5.6M | ||
| Q3 25 | $57.7M | $23.0M | ||
| Q2 25 | $70.1M | $21.2M | ||
| Q1 25 | $58.8M | $19.4M | ||
| Q4 24 | $68.8M | $16.7M | ||
| Q3 24 | $76.1M | $20.6M | ||
| Q2 24 | $28.9M | $14.6M | ||
| Q1 24 | $47.7M | $12.0M |
| Q4 25 | $106.0M | — | ||
| Q3 25 | $105.3M | — | ||
| Q2 25 | $102.7M | — | ||
| Q1 25 | $77.4M | — | ||
| Q4 24 | $77.5M | — | ||
| Q3 24 | $76.9M | — | ||
| Q2 24 | $11.2M | — | ||
| Q1 24 | $11.3M | $2.5M |
| Q4 25 | $346.6M | $85.8M | ||
| Q3 25 | $349.3M | $82.8M | ||
| Q2 25 | $355.5M | $78.7M | ||
| Q1 25 | $347.1M | $74.2M | ||
| Q4 24 | $354.6M | $71.9M | ||
| Q3 24 | $370.9M | $71.5M | ||
| Q2 24 | $371.3M | $68.0M | ||
| Q1 24 | $370.6M | $63.5M |
| Q4 25 | $508.6M | $105.6M | ||
| Q3 25 | $493.5M | $109.5M | ||
| Q2 25 | $503.6M | $98.3M | ||
| Q1 25 | $470.3M | $93.7M | ||
| Q4 24 | $473.2M | $90.5M | ||
| Q3 24 | $489.3M | $91.3M | ||
| Q2 24 | $430.8M | $84.9M | ||
| Q1 24 | $437.2M | $82.8M |
| Q4 25 | 0.31× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.29× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.22× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | 0.03× | 0.04× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.3M | $267.0K |
| Free Cash FlowOCF − Capex | $9.7M | $-17.4M |
| FCF MarginFCF / Revenue | 15.8% | -31.5% |
| Capex IntensityCapex / Revenue | 1.0% | 31.9% |
| Cash ConversionOCF / Net Profit | — | 0.11× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.0M | $-16.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.3M | $267.0K | ||
| Q3 25 | $-581.0K | $6.9M | ||
| Q2 25 | $-10.5M | $3.9M | ||
| Q1 25 | $-4.2M | $-150.0K | ||
| Q4 24 | $-4.0M | $-2.6M | ||
| Q3 24 | $-10.3M | $7.5M | ||
| Q2 24 | $-6.1M | $6.5M | ||
| Q1 24 | $-6.7M | $1.5M |
| Q4 25 | $9.7M | $-17.4M | ||
| Q3 25 | $-3.4M | $1.8M | ||
| Q2 25 | $-13.9M | $1.6M | ||
| Q1 25 | $-8.4M | $-2.4M | ||
| Q4 24 | $-4.2M | $-3.8M | ||
| Q3 24 | $-11.7M | $5.9M | ||
| Q2 24 | $-12.8M | $5.1M | ||
| Q1 24 | $-13.2M | $-923.0K |
| Q4 25 | 15.8% | -31.5% | ||
| Q3 25 | -5.6% | 3.1% | ||
| Q2 25 | -22.8% | 3.0% | ||
| Q1 25 | -16.0% | -5.1% | ||
| Q4 24 | -8.1% | -8.2% | ||
| Q3 24 | -21.4% | 12.8% | ||
| Q2 24 | -24.2% | 10.4% | ||
| Q1 24 | -29.4% | -2.1% |
| Q4 25 | 1.0% | 31.9% | ||
| Q3 25 | 4.6% | 9.0% | ||
| Q2 25 | 5.6% | 4.3% | ||
| Q1 25 | 8.1% | 4.8% | ||
| Q4 24 | 0.5% | 2.7% | ||
| Q3 24 | 2.5% | 3.3% | ||
| Q2 24 | 12.7% | 2.9% | ||
| Q1 24 | 14.5% | 5.5% |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 1.96× | ||
| Q2 25 | — | 0.92× | ||
| Q1 25 | — | -0.04× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.50× | ||
| Q2 24 | — | 1.73× | ||
| Q1 24 | — | 0.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KIDS
Segment breakdown not available.
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |
